Skip To Main Content
BR Nagarjun on Muck Rack

BR Nagarjun

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with BR

Contact BR, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Minimal residual disease evaluation by flow cytometry in B cell acute lymphoblastic leukemia (BCP-ALL) and its outcome in children and adults

|
By Gujarat Cancer, Hemangini H Vora, BR Nagarjun, Biren Parikh
| asjo.in
A prospective study was conducted in patients diagnosed with BCP-ALL at a Regional Cancer Center in Gujarat from 1 November 2019 to 31 May 2022. It included all the diagnosed cases of BCP-ALL patients in whom MRD was assessed post-induction. The diagnosis of BCP-ALL was based on morphology, cytochemistry, and immunophenotypic antigen expression as per the WHO 2016 criteria. Bone marrow (BM) examination was simultaneously done with MRD assessment.
Open in Who Shared Issue with article?
See all 1 articles